PAA 8.89% 24.5¢ pharmaust limited

Ann: Board Changes, page-222

  1. 2,482 Posts.
    lightbulb Created with Sketch. 1409
    Hi @1001reuben,

    Welcome to HC, I think you raise some very pertinent points, I have twice said on here recently, we may attract a low ball offer, for obvious reasons. From whom, who knows. Amylyx are facing the possibility of a class action at the moment, who knows how that would effect them in considering making an offer, too much on their hands or a ticket out of jail. Personally I don't care who makes an offer, it is the amount that's important. Due to the threat/chance of a TA or BO, I would be surprised if Merchant are selling, but that's just a guess.

    My point is, I would be surprised if someone is not at lest thinking about it.

    What would be a low ball offer ? A billion US ? Half that ? Will an offer from what is still a small company like Amylxy [ By international standards] encourage a bigger player come in ?

    I'm a top 50 holder, so even the smaller example would put a million $A in my bank and there are 40 something bigger holders, some much much bigger. Having said that I would recommend the board reject any such offer and seek more. Ultimately I think PAA could be worth a lot more.

    So I think holders should listen to what you are saying and hold tight, possibly even pick up more if they can.

    Like you and many others I'm looking forward to BOD telling us where we are, and what is their strategy.

    Cheers


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.020(8.89%)
Mkt cap ! $96.99M
Open High Low Value Volume
22.5¢ 24.5¢ 22.5¢ $150.8K 649.5K

Buyers (Bids)

No. Vol. Price($)
2 30000 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 50607 2
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
24.0¢
  Change
0.020 ( 6.67 %)
Open High Low Volume
22.5¢ 24.0¢ 22.5¢ 231366
Last updated 15.56pm 17/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.